Cardiologist Jerry Blackwell, MD, president and CEO of MedAxiom, believes cardiologist can't just focus on clinical decisions, as they also must be aware the financial ramifications.
With cardiovascular disease on the rise, clinicians and health systems continue to look for ways to deliver high-quality care that is both timely and cost-effective.
The Myval TAVR valve. Image courtesy of Merit Life Sciences.
The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care.
The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.
One of the biggest decisions in a cardiologist's life is knowing when, exactly, to start a family. Nandita S. Scott, MD, co-director of the Corrigan Women's Heart Health Program at Mass General Hospital, shared her perspective on this important topic.
HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results.
